BREYORA Trademark

Trademark Overview


On Tuesday, August 14, 2018, a trademark application was filed for BREYORA with the United States Patent and Trademark Office. The USPTO has given the BREYORA trademark a serial number of 88077682. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 15, 2022. This trademark is owned by Novartis AG. The BREYORA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
breyora

General Information


Serial Number88077682
Word MarkBREYORA
Filing DateTuesday, August 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 15, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 6, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment of genetic diseases and disorders and pharmaceutical preparations for use in enzyme therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, August 15, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 15, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 14, 2022SOU EXTENSION 5 GRANTED
Thursday, January 6, 2022SOU EXTENSION 5 FILED
Friday, January 14, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 5, 2021SOU EXTENSION 4 GRANTED
Monday, July 5, 2021SOU EXTENSION 4 FILED
Monday, July 5, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 5, 2021SOU EXTENSION 3 GRANTED
Tuesday, January 5, 2021SOU EXTENSION 3 FILED
Tuesday, January 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 3, 2020SOU EXTENSION 2 GRANTED
Friday, July 3, 2020SOU EXTENSION 2 FILED
Friday, July 3, 2020SOU TEAS EXTENSION RECEIVED
Thursday, January 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 7, 2020SOU EXTENSION 1 GRANTED
Tuesday, January 7, 2020SOU EXTENSION 1 FILED
Tuesday, January 7, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 30, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, May 28, 2019ASSIGNED TO PETITION STAFF
Thursday, May 16, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, May 2, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, December 5, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 24, 2018ASSIGNED TO EXAMINER
Wednesday, August 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 17, 2018NEW APPLICATION ENTERED